Low expression of PTK6/Brk predicts poor prognosis in patients with laryngeal squamous cell carcinoma

BACKGROUND: Protein tyrosine kinase 6 (PTK6), also known as breast tumor kinase (Brk), was a nonreceptor tyrosine kinase containing SH3, SH2, and tyrosine kinase catalytic domains. The deregulated expression of PTK6 was observed in various human cancers. However, little was known about PTK6 expressi...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Xue-Kui, Zhang, Xin-Rui, Zhong, Qian, Li, Man-Zhi, Liu, Zhi-Min, Lin, Zhi-Rui, Wu, Di, Zeng, Mu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599503/
https://www.ncbi.nlm.nih.gov/pubmed/23497344
http://dx.doi.org/10.1186/1479-5876-11-59

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3599503/
https://www.ncbi.nlm.nih.gov/pubmed/23497344
http://dx.doi.org/10.1186/1479-5876-11-59

Ejemplares similares